Christopher Swale is a scientist at INSERM, currently serving as a Staff Research Scientist since 2022, where they focus on developing therapeutic targets against infectious diseases. They previously held positions as a Postdoctoral Researcher at INSERM and the Centre National de la Recherche Scientifique, specializing in the structural biology of Apicomplexan drug targets. Christopher completed a PhD in Structural Biology at Université Grenoble Alpes, where they also obtained a Master's degree in Autoimmunity from Universidad de Granada. Throughout their career, they have been dedicated to the integration of new technologies into their research on infectious diseases, including their work on the influenza A virus and various Apicomplexan parasites.
This person is not in the org chart
This person is not in any teams
This person is not in any offices